These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35018443)

  • 1. Letter to the Editor From Singhania et al: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults".
    Singhania P; Bhattacharjee R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2202-e2203. PubMed ID: 35018443
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults: Age and Diabetes in COVID-19 Severity".
    Woolcott OO; Castilla-Bancayán JP
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5273-e5274. PubMed ID: 34363481
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults".
    Diedisheim M; Dancoisne E; Gautier JF; Larger E; Cosson E; Fève B; Chanson P; Czernichow S; Tatulashvili S; Raffin-Sanson ML; Sallah K; Bourgeon M; Ajzenberg C; Hartemann A; Daniel C; Moreau T; Roussel R; Potier L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5277-e5278. PubMed ID: 34370033
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.).
    Hussain A; do Vale Moreira NC
    Diabetes Metab Syndr; 2020; 14(4):363. PubMed ID: 32325393
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor: Diabetes, obesity and hypertension may promote oral SARS-CoV-2 infection-Salivary soluble ACE2 perspective.
    Roganović J; Radenković M
    Oral Dis; 2022 Apr; 28 Suppl 1():1005-1007. PubMed ID: 33141469
    [No Abstract]   [Full Text] [Related]  

  • 7. TB and COVID-19: paying attention to diabetes mellitus.
    Harries AD; Kumar AMV; Satyanarayana S; Lin Y; Dlodlo RA; Khogali M; Zachariah R; Kapur A
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):600-602. PubMed ID: 34075400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diabetes mellitus in the clinical course and outcome of SARS-CoV-2 infected patients.
    Maltezou HC; Pavli A; Tsonou P; Balaska A; Raftopoulos V; Papadima K; Andreopoulou A; Tentolouris A; Gamaletsou MN; Sipsas NV; Tentolouris N
    Hormones (Athens); 2022 Jun; 21(2):221-227. PubMed ID: 35138606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
    Jayaram A; Buhimschi IA; Buhimschi CS
    Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study".
    Gregory JM; Moore DJ
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1763-e1764. PubMed ID: 34871421
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Letter to the Editor from Justin M. Gregory: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study".
    Demeterco-Berggren C; Ebekozien O; Levy CJ; Maahs DM
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1769-e1770. PubMed ID: 34871436
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
    Klonoff DC; Umpierrez GE
    Metabolism; 2020 Jul; 108():154224. PubMed ID: 32275971
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor from Speeckaert et al: "Vitamin D Deficiency Is Associated With Higher Hospitalization Risk from COVID-19: a Retrospective Case-control Study".
    Speeckaert MM; Delanghe JR
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e432-e433. PubMed ID: 34529788
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".
    Kokic Males V
    Diabetes Res Clin Pract; 2020 May; 163():108163. PubMed ID: 32333972
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'.
    Ghoshal S;
    Diabetes Metab Syndr; 2020; 14(5):1541. PubMed ID: 32947752
    [No Abstract]   [Full Text] [Related]  

  • 17. The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.
    McGovern AP; Thomas NJ; Vollmer SJ; Hattersley AT; Mateen BA; Dennis JM
    Diabetologia; 2021 May; 64(5):1184-1186. PubMed ID: 33594475
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19.
    Mukhtar S; Mukhtar S
    Metabolism; 2020 Jul; 108():154248. PubMed ID: 32335075
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Viola V; Leanza G; Tramontana F
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5271-e5272. PubMed ID: 34383045
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.